[Pneumonia in clinical practice: diagnosis and therapy]

W Zimmerli1

  • 1Departement für Innere Medizin, Universitätskliniken, Kantonsspital Basel.

Praxis
|December 6, 1994
PubMed

Insights

Empirical treatment of pneumonia requires knowing common causes. For outpatients, viruses and atypical bacteria are frequent, while hospitalized patients more often have pneumococci and Hemophilus.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Context:

  • Community-acquired pneumonia (CAP) management relies on empirical treatment due to diagnostic challenges.
  • Understanding the specific microbial etiology of pneumonia in outpatients versus hospitalized patients is crucial for effective therapy.

Purpose:

  • To delineate the common causative agents of pneumonia in outpatient settings and compare them to hospitalized patients.
  • To evaluate the utility of microbiological diagnostic methods, specifically sputum Gram stain and culture, in identifying pneumonia pathogens.
  • To provide evidence-based treatment recommendations for outpatients with pneumonia based on likely etiologies and risk factors.

Summary:

  • In outpatients, pneumonia is caused by viruses (30%), atypical bacteria (45%), and typical bacteria (25%). Hospitalized patients show a higher prevalence of typical bacteria (60%).
  • Sputum Gram stain is the most valuable microbiological test for outpatients; sputum culture is often unreliable.
  • Recommended outpatient treatment includes macrolides for healthy individuals and amoxicillin/clavulanic acid or cephalosporins for those with risk factors.

Impact:

  • Informed empirical treatment strategies for community-acquired pneumonia.
  • Improved diagnostic approaches by highlighting the role of sputum Gram stain.
  • Optimized antibiotic selection, potentially reducing resistance and improving patient outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...